Retatrutide 20mg
IMPORTANT
This product is supplied as sterile lyophilised powder and is intended for Research Use Only (RUO). It is not intended for human or veterinary use, nor for the diagnosis, treatment, prevention, or cure of any disease or medical condition.
Also known as: Triple G Agonist, Triple Incretin Agonist, Retatrutide.
PRODUCT DESCRIPTION
Retatrutide is a synthetic peptide currently being investigated for its activity at the GLP-1, GIP, and glucagon receptors. Its triple receptor agonist mechanism has attracted significant scientific interest in preclinical research involving metabolism, energy balance, and hormonal signalling pathways.
Laboratory studies are investigating the potential role of Retatrutide in glucose metabolism, energy homeostasis, and various metabolic processes. The product is supplied as a sterile lyophilised powder, helping to maintain stability when stored under the recommended conditions.
INFORMATION ON DOSES USED IN RESEARCH
Retatrutide has an approximate half-life of 7 days, and in clinical research it has generally been investigated using once-weekly administration.
Published clinical studies have commonly started with doses of 0.25–0.5 mg once weekly, with gradual dose escalation every 3–4 weeks, depending on the study protocol and research objectives.
The most frequently investigated dose range in clinical studies has been 2–8 mg once weekly.
Please Note: This information is provided for educational and informational purposes only and reflects dosing protocols reported in publicly available clinical research. It is not intended as dosing guidance or medical advice.
RESEARCH APPLICATIONS
- GLP-1, GIP, and glucagon receptor activity studies
- Metabolism and energy expenditure research
- Hormonal signalling pathway investigations
- Preclinical models of body weight regulation
- Glucose metabolism and energy balance research
STORAGE CONDITIONS
- Store unopened sterile lyophilised powder at 2–8°C for short-term storage.
- For extended storage, keep frozen according to laboratory protocols.
- After reconstitution, store at 2–8°C and use within 28 days, unless laboratory stability data or the manufacturer's specifications indicate otherwise.
- Avoid repeated freeze-thaw cycles.
- Protect from direct sunlight and moisture.
- Store in the original, tightly sealed vial.
ADDITIONAL INFORMATION
Active Ingredient: Retatrutide
Chemical Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Form: Sterile Lyophilised Powder
Quantity: 20mg per vial
WARNING
This product is intended for Research Use Only (RUO) and is not approved as a medicinal product.
It is not intended for human or veterinary use, nor for the diagnosis, treatment, prevention, or cure of any disease or medical condition.
This product should be handled only by qualified professionals in appropriately equipped research laboratories, in accordance with applicable laws, regulations, and good laboratory practice (GLP).